Regis Healthcare Ltd
ASX:REG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regis Healthcare Ltd
ASX:REG
|
AU |
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
AU |
|
Softronic AB
STO:SOF B
|
SE |
|
Atlantic Sapphire ASA
OSE:ASA
|
NO |
|
Lovisa Holdings Ltd
F:LO7
|
AU |
|
Moskovskiy Kreditnyi Bank PAO
MOEX:CBOM
|
RU |
|
Abivax SA
PAR:ABVX
|
FR |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
O
|
Oconee Federal Financial Corp
OTC:OFED
|
US |
|
A
|
Aeffe SpA
F:3A1
|
IT |
|
Mind Gym PLC
LSE:MIND
|
UK |
Wall Street
Price Targets
REG Price Targets Summary
Regis Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
REG
is 8.67 AUD
with a low forecast of 8.08 AUD and a high forecast of 9.45 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REG's stock price target?
Price Target
8.67
AUD
According to Wall Street analysts, the average 1-year price target for
REG
is 8.67 AUD
with a low forecast of 8.08 AUD and a high forecast of 9.45 AUD.
What is Regis Healthcare Ltd's Revenue forecast?
Projected CAGR
12%
For the last 12 years the
compound annual growth rate for
Regis Healthcare Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
12%.
What is Regis Healthcare Ltd's Operating Income forecast?
Projected CAGR
29%
For the last 12 years the
compound annual growth rate for
Regis Healthcare Ltd's operating income is
3%.
The projected
CAGR
for the next 3 years is
29%.
What is Regis Healthcare Ltd's Net Income forecast?
Projected CAGR
22%
For the last 12 years the
compound annual growth rate for
Regis Healthcare Ltd's net income is
9%.
The projected
CAGR
for the next 3 years is
22%.
